| 27th Feb 2023 8:48 am |
RNS |
Form 8.5 (EPT/RI) |
| 24th Feb 2023 5:18 pm |
RNS |
Form 8.3 - REDX Pharma PLC |
| 24th Feb 2023 3:13 pm |
RNS |
Replacement Form 8.3 - Jounce Therapeutics, Inc. |
| 24th Feb 2023 2:02 pm |
RNS |
Form 8.3 - Jounce Therapeutics, Inc. |
| 24th Feb 2023 10:18 am |
RNS |
Form 8.5 (EPT/RI) |
| 24th Feb 2023 7:00 am |
RNS |
Form 8.3 - Redx Pharma plc |
| 23rd Feb 2023 7:15 am |
RNS |
Recommended Business Combination |
| 23rd Feb 2023 7:01 am |
RNS |
Recommended Business Combination |
| 15th Feb 2023 4:38 pm |
RNS |
Notice of AGM |
| 9th Feb 2023 7:00 am |
RNS |
Progress Update on RXC007 Clinical Programme |
| 23rd Jan 2023 7:00 am |
RNS |
Redx to Present at Wnt & ß-Catenin Pathway Summit |
| 21st Dec 2022 7:00 am |
RNS |
New Grant of Options |
| 20th Dec 2022 7:00 am |
RNS |
Final Results for the Year Ended 30 September 2022 |
| 16th Dec 2022 7:00 am |
RNS |
Clinical Trial Agreement with MSD |
| 13th Dec 2022 7:00 am |
RNS |
Notice of Preliminary Results |
| 17th Nov 2022 7:00 am |
RNS |
Redx to Present Poster at IBD Nordic Conference |
| 10th Nov 2022 2:00 pm |
RNS |
RXC004 Phase 2 Combination Arms to Open Enrolment |
| 10th Nov 2022 7:00 am |
RNS |
Redx to Present at Jefferies London |
| 7th Nov 2022 7:00 am |
RNS |
Redx Presenting at AFDD meeting |
| 3rd Nov 2022 7:00 am |
RNS |
Redx to Present RXC004 Phase 1 Combination Data |
| 27th Oct 2022 7:00 am |
RNS |
Redx to Present Poster at ASN Kidney Week |
| 11th Oct 2022 7:00 am |
RNS |
First Patient Dosed in Phase 2a Trial for RXC007 |
| 3rd Oct 2022 7:00 am |
RNS |
Redx Presents RXC007 Preclinical and Phase 1 Data |
| 29th Sep 2022 7:41 am |
RNS |
Redx to Present Poster on RXC007 at ICLAF |
| 6th Sep 2022 7:00 am |
RNS |
TR-1: Notification of major holdings |
| 31st Aug 2022 7:00 am |
RNS |
Redx to Present at the ERS International Congress |
| 5th Aug 2022 11:52 am |
RNS |
Completion of Placing and Director/PDMR Dealings |
| 3rd Aug 2022 1:43 pm |
RNS |
Proposed Secondary Placing of Shares via ABB |
| 26th Jul 2022 1:47 pm |
RNS |
Exercise of Options, PDMR Dealing and TVR |
| 11th Jul 2022 7:00 am |
RNS |
Redx to Present at Virtual Investor Forum |
| 27th Jun 2022 7:00 am |
RNS |
Encouraging Data on Porcupine and ROCK Inhibitors |
| 23rd Jun 2022 7:00 am |
RNS |
Interim Results for the Six Months Ended 31 March |
| 20th Jun 2022 7:00 am |
RNS |
Redx to Present at the ECM Congress |
| 16th Jun 2022 7:00 am |
RNS |
Notice of Interim Results |
| 15th Jun 2022 7:00 am |
RNS |
Pan-RAF Inhibitor to Enter Clinical Development |
| 9th Jun 2022 4:34 pm |
RNS |
TR-1: Notification of major holdings |
| 8th Jun 2022 1:28 pm |
RNS |
TR-1: Notification of major holdings |
| 7th Jun 2022 8:11 am |
RNS |
Admission of Placing Shares |
| 6th Jun 2022 11:56 am |
RNS |
Results of General Meeting |
| 30th May 2022 7:00 am |
RNS |
Redx Presents Poster on RXC004 at ASCO |
